Novartis AG Common Stock (NVS)

Depreciation & Amortization

$1.20B

Quarterly · Period ending: · USD

NVS logo

NVS Depreciation & Amortization

Latest reported$1.20B
NVS Quarterly Depreciation & Amortization ($244.00M → $1.20B)
High-resolution chart · PNG

NVS depreciation & amortization history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Novartis AG Common Stock Depreciation & Amortization — Quarterly (USD)
Period endingDepreciation & Amortization (USD)
1,200,822,507
1,228,000,000
1,551,000,000
1,364,000,000
1,256,000,000
1,154,000,000
1,628,000,000
1,965,000,000
1,162,000,000
1,314,000,000
1,588,000,000
3,111,000,000
1,708,000,000
1,870,000,000
1,948,000,000
1,915,000,000
1,802,000,000
1,405,000,000
1,519,000,000
1,453,000,000
1,444,000,000
1,697,000,000
1,617,000,000
1,734,000,000
1,703,000,000
1,410,000,000
1,937,000,000
1,402,000,000
1,046,000,000
1,441,000,000
1,959,000,000
1,365,000,000
1,205,000,000
1,005,000,000
1,468,000,000
1,478,000,000
1,354,000,000
1,776,000,000
1,832,000,000
1,508,000,000
1,466,000,000
1,369,000,000
1,325,000,000
1,355,000,000
1,509,000,000
1,282,000,000
1,222,000,000
1,167,000,000
1,175,000,000
1,118,000,000
1,259,000,000
1,097,000,000
1,118,000,000
1,194,000,000
1,350,000,000
1,232,000,000
1,194,000,000
1,144,000,000
1,772,000,000
1,428,000,000
1,383,000,000
1,205,000,000
756,000,000
1,237,000,000
665,000,000
761,000,000
589,000,000
614,000,000
550,000,000
548,000,000
551,000,000
861,000,000
624,000,000
634,000,000
785,000,000
953,000,000
580,000,000
540,000,000
516,000,000
563,000,000
408,000,000
428,000,000
640,000,000
498,000,000
294,000,000
285,000,000
311,000,000
330,000,000
316,000,000
309,000,000
329,000,000
361,000,000
289,000,000
304,000,000
-84,000,000
244,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.